Key facts
as of Sep 2026- It has raised $13.9M; the latest was Early Stage VC in Aug 2025.
- Notable investors include CAS Star, Zhejiang Caitong Capital Investment, Hangzhou Huadian Investment Management, Huzhou Industrial Group, Kaitai Capital — 8 tracked in total.
- 1 institutional filer reports fund marks on China Boron Neutron across 19 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for China Boron Neutron
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in China Boron Neutron shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
1 filers · latest Mar 20261 SEC-registered fund reported 19 fair-value marks on China Boron Neutron between Dec 2025 and Mar 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for China Boron Neutron are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About China Boron Neutron
Manufacturer of boron neutron capture therapy devices aims to advance innovative cancer diagnosis and treatment. The company's offerings feature medical accelerator-based neutron sources, boron-containing targeted drugs, and diagnostic-therapeutic software platforms, supported by complete industrialization workflows and independent intellectual property rights, enabling the clinical application and commercialization of advanced BNCT for late-stage malignant tumors.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2023
- Website
- chbnct.com/
- Ownership
- Privately Held (backing)